Tiziana Life Sciences Announces an Expedited Clinical Development Plan for Its Anti-Interleukin-6-Receptor, a Fully Human Monoclonal Antibody, for the Treatment of COVID-19 Patients

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

Frank X. Powers
Healthcare Challenger Brands

Amy Giles
Increasing Engagement

Frank Burrell
Scientific Storytelling

Laura Blair
Medication Adherence

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy

Mike Viscel
Increasing Engagement

Bud Bilanich
Success Coach

David Linetsky
Patient Activation

Stacey Gandler
Brand Nourishment

Anil Bhaskar
Unified Customer Experience

Thomas Shea
Programmatic Marketing

Pat Purcell
Meeting Engagement

Matthew Durham
Omnidynamic Marketing

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access